Hot Features
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cance... Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.91 | 1.8922852984 | 48.09 | 50.54 | 44.931 | 1528086 | 48.27022032 | CS |
| 4 | 8.24 | 20.2158979392 | 40.76 | 50.54 | 37.66 | 1190620 | 44.33584051 | CS |
| 12 | 17.74 | 56.7498400512 | 31.26 | 50.54 | 29.455 | 1023312 | 37.7448648 | CS |
| 26 | 1.62 | 3.41916420431 | 47.38 | 50.54 | 29.455 | 923466 | 38.49545024 | CS |
| 52 | 21.49 | 78.1170483461 | 27.51 | 50.71 | 22.61 | 1064838 | 34.39468222 | CS |
| 156 | 22.57 | 85.3953840333 | 26.43 | 50.71 | 18.61 | 861707 | 31.19374153 | CS |
| 260 | 15.41 | 45.8767490325 | 33.59 | 54.13 | 14.85 | 839003 | 29.85594301 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.